Publication: 4277

Publication: 4277

A Clinical-Genetic (CG) Circulating Tumor DNA (ctDNA)-based Prognostic Model for Predicting Overall Survival (OS) in Metastatic Castrate-Resistant Prostate Cancer (mCRPC) Men Treated with Potent Androgen Reception Inhibition (Alliance)

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 24 (16_suppl) 5007

Meeting Instance:: ASCO 2024
Year:: 2024
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epreprint

Note:

Methodological:: No
Biospecimen:: No
SDC:: Yes

Parents:: None
Children:: 4376

Program:: OGC
Primary Committee:: GU
Sec. Committees:

Pharmas:: Astellas
Grants:: U10CA180821, U10CA180882; 5R01-CA256157

Corr. Author:
Authors:: Susan Halabi Bin Luo Siyuan Guo Todd Knutson Anna Kobilka Jacqueline Lyman Himisha Beltran Charles J. Ryan W. Kevin Kelly Emmanuel Antonarakis Jonathan E. Rosenberg Matthew Galsky Eric J. Small Michael J. Morris Scott M. Dehm Andrew J. Armstrong

Networks:: CA824, LAPS-MA036, LAPS-NC010, LAPS-NY016, MN022, NY021

Study: Alliance-A031201
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: